Vaccinations
Immunological Memory
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 10, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Dawid S Zyla1, Gillian Zipursky2,3, Roberta Della Marca2,3,4
1Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Developing stabilized measles virus (MeV) fusion (F) protein antigens offers a promising strategy for next-generation vaccines. Thermostable full-length F protein elicits superior immune responses compared to ectodomain, providing potential for immunocompromised individuals.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: